Saturday, July 11, 2026

Drug profile · INN

edrophonium chloride

edrophonium chloride (TENSILON) is a acetylcholinesterase inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — edrophonium chloride
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

edrophonium chloride (TENSILON) is a acetylcholinesterase inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN edrophonium chloride
Brand TENSILON
Mechanism Acetylcholinesterase inhibitor
Target Acetylcholinesterase
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Acetylcholinesterase inhibitor

Primary target: Acetylcholinesterase

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. benzgalantamine gluconate Acetylcholinesterase inhibitor
  2. donepezil hydrochloride Acetylcholinesterase inhibitor
  3. neostigmine methylsulfate Acetylcholinesterase inhibitor
  4. pyridostigmine bromide Acetylcholinesterase inhibitor
  5. ambenonium chloride Acetylcholinesterase inhibitor
  6. demecarium bromide Acetylcholinesterase inhibitor

Frequently asked questions

What is edrophonium chloride?

edrophonium chloride (TENSILON) is a acetylcholinesterase inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for edrophonium chloride?

TENSILON is a marketed brand name for edrophonium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of edrophonium chloride?

edrophonium chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.